Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical
unmet needs.
unmet needs.
Location: United States, Massachusetts, Boston
Employees: 11-50
Founded date: 2017
Investors 8
Mentions in press and media 15
| Date | Title | Description |
| 20.04.2023 | Humans can't live forever, but we haven't even come close to the limit for how long our bodies could last | Millions of dollars are going toward companies worldwide looking to lengthen the human lifespan. invincible_bulldog / Getty Images Redeem now Researchers estimate that the human body may not be capable of living more than 150 years. But doz... |
| 10.03.2023 | Tweekly. Выпуск 160. Бессмертие как сервис | Что сейчас растёт и как это применить 1. Бессмертие как сервис (IaaS). То, чего все хотят и боятся одновременно. 2. Цифровые клоны городов и производств — быстрая проверка «капиталоемких» гипотез. Следующий шаг - проверка жизнеспособности п... |
| 25.10.2022 | Want To Live Longer? How Life Extension Industry Will Reboot Health, Wellness and The Economy | Do you want to live a better, healthier and longer life? Me too. |
| 01.07.2021 | Life Biosciences : Appoints Seasoned Biopharma Executive Jerry McLaughlin as CEO | BOSTON, July 1, 2021 /PRNewswire/ -- Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced that the Company's Board of Directors has appointed Jerry McLaughlin as Chief Executive Officer and a ... |
| 01.07.2021 | Life Biosciences Appoints Seasoned Biopharma Executive Jerry McLaughlin as CEO | |
| 22.04.2021 | Life Biosciences Announces Publication in Cell Demonstrating Therapeutic Benefit of Chaperone-Mediated Autophagy Activators in Alzheimer's Disease Models | |
| 14.04.2021 | Life Biosciences to Present at 5th Stanford Drug Discovery Symposium | |
| 14.04.2021 | Life Biosciences : to Present at 5th Stanford Drug Discovery Symposium | BOSTON, April 14, 2021 /PRNewswire/ -- Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced that Joan Mannick, MD, Head of Research and Development, will participate in the 5th Stanford Drug D... |
| 18.02.2021 | Life Biosciences Announces Pioneering Research in Nature Describing New Mechanisms for Reversing Age-Related Disease | |
| 03.06.2020 | Dinbeat cierra una ronda de inversión de €500.000 en la que participan IESE Ban, Afintia, Accelgrow y otros BA | 03/06/2020 Nota de prensa DINBEAT CIERRA UNA RONDA DE €500.000 EN LA QUE PARTICIPAN IESE BAN, AFINTIA, ACCELGROW Y OTROS BA. Dinbeat, startup especializada en el desarrollo de productos innovadores y tecnológicos para el sector de la mas... |
Show more